COM:FOGHORNTX
Foghorn Therapeutics Inc.
- Stock
Last Close
7.72
22/11 21:00
Market Cap
265.58M
Beta: -
Volume Today
100.07K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | |||||||
average payables | 2.73M - | 3.56M 30.55% | 3.75M 5.34% | 4.62M 23.12% | 5.84M 26.44% | ||
average receivables | 150M - | 150M 0% | |||||
book value per share | -2.00 - | -3.98 98.81% | 13.23 432.69% | 2.61 80.31% | 0.00 99.90% | -0.00 168.29% | |
capex per share | -0.08 - | -0.04 44.27% | -1.46 3,248.71% | -0.09 93.92% | -0.03 67.36% | -0.00 99.90% | |
capex to depreciation | -4.07 - | -1.40 65.65% | -12.20 773.06% | -1.03 91.58% | -0.36 64.51% | -0.35 2.65% | |
capex to operating cash flow | 0.07 - | 0.02 69.30% | 0.52 2,375.96% | 0.07 87.25% | -0.01 109.48% | 0.01 265.83% | |
capex to revenue | -37.63 - | -2.51 93.33% | -0.06 97.49% | -0.04 43.05% | |||
cash per share | 2.04 - | 0.68 66.79% | 16.82 2,383.87% | 4.15 75.32% | 15.37 270.36% | 0.01 99.96% | |
days of inventory on hand | |||||||
days payables outstanding | 102.77K - | ||||||
days sales outstanding | 83.02K - | ||||||
debt to assets | 0.16 - | 0.74 355.94% | 0.32 56.90% | 0.11 65.02% | 0.13 13.36% | 0.16 23.92% | |
debt to equity | -0.18 - | -0.19 5.56% | 0.56 396.88% | 0.60 7.36% | 459.88 76,272.17% | -0.58 100.13% | |
dividend yield | |||||||
earnings yield | -0.07 - | -0.13 74.03% | -0.31 141.82% | -0.12 61.03% | -0.41 237.89% | -0.00 99.91% | |
enterprise value | 322.70M - | 402.60M 24.76% | 213.12M 47.06% | 807.30M 278.80% | -28.94M 103.58% | 270.70B 935,559.82% | |
enterprise value over ebitda | -12.63 - | -8.07 36.10% | -3.22 60.10% | -8.50 164.10% | 0.25 102.91% | -2.51K 1,015,585.30% | |
ev to operating cash flow | -14.25 - | -8.69 39.02% | -6.81 21.60% | -16.07 135.84% | -0.15 99.07% | -2.29K 1,533,405.89% | |
ev to sales | 495.63 - | 612.05 23.49% | -1.50 100.25% | 7.93K 526,729.23% | |||
free cash flow per share | -1.23 - | -2.14 73.48% | -4.30 101.01% | -1.44 66.47% | 4.63 421.03% | -0.00 100.06% | |
free cash flow yield | -0.07 - | -0.12 73.48% | -0.21 79.69% | -0.06 70.28% | 0.73 1,250.78% | -0.00 100.06% | |
graham net net | -2.16 - | -4.31 99.97% | 6.91 260.37% | -1.17 116.97% | 5.64 580.76% | -0.00 100.05% | |
graham number | 7.77 - | 14.46 86.01% | 43.37 200.00% | 12.76 70.58% | 0.40 96.88% | 0.01 97.53% | |
income quality | 0.86 - | 0.91 5.39% | 0.45 49.82% | 0.50 9.06% | -1.78 458.54% | 1.20 167.48% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -70.21 - | -94.60 34.73% | -70.00 26.00% | -52.85 24.50% | 10.13 119.16% | ||
interest debt per share | 0.38 - | 0.78 105.82% | 7.51 868.05% | 1.62 78.42% | 0.96 40.74% | 0.00 99.89% | |
inventory turnover | |||||||
invested capital | -0.18 - | -0.19 5.56% | 0.56 396.88% | 0.60 7.36% | 459.88 76,272.17% | -0.58 100.13% | |
market cap | 355.69M - | 400.95M 12.73% | 223.92M 44.15% | 850.10M 279.65% | 265.35M 68.79% | 270.74B 101,928.27% | |
net current asset value | -41.93M - | -93.47M 122.93% | 81.28M 186.96% | 36.66M 54.90% | -58.97M 260.87% | -122.92M 108.44% | |
net debt to ebitda | 1.29 - | -0.03 102.56% | 0.16 593.87% | 0.45 176.35% | 2.51 457.33% | 0.33 86.99% | |
net income per share | -1.34 - | -2.34 74.03% | -6.32 170.52% | -2.78 56.04% | -2.62 5.74% | -0.00 99.91% | |
operating cash flow per share | -1.15 - | -2.09 81.49% | -2.83 35.25% | -1.35 52.27% | 4.66 444.35% | -0.00 100.06% | |
payables turnover | 0.00 - | ||||||
receivables turnover | 0.00 - | ||||||
research and ddevelopement to revenue | 134.22 - | 60.90 54.63% | 5.49 90.98% | 3.21 41.53% | |||
return on tangible assets | -0.61 - | -2.31 278.08% | -0.27 88.19% | -0.20 27.26% | -0.27 35.40% | -0.34 28.02% | |
revenue per share | 0.04 - | 0.04 8.84% | 0.46 1,202.84% | 0.00 99.82% | |||
roe | 0.67 - | 0.59 12.46% | -0.48 181.31% | -1.07 123.24% | -972.09 91,124.15% | 1.28 100.13% | |
roic | 0.81 - | 0.74 8.83% | -0.24 132.38% | -0.48 100.89% | -1.14 136.32% | -7.96 600.40% | |
sales general and administrative to revenue | 26.15 - | 16.47 37.01% | 1.60 90.29% | 0.95 40.73% | |||
shareholders equity per share | -2.00 - | -3.98 98.81% | 13.23 432.69% | 2.61 80.31% | 0.00 99.90% | -0.00 168.29% | |
stock based compensation to revenue | 6.89 - | 6.36 7.69% | 0.75 88.27% | 0.47 36.44% | |||
tangible asset value | -39.27M - | -88.02M 124.11% | 146.19M 266.09% | 96.87M 33.73% | 112K 99.88% | -77.19M 69,019.64% | |
tangible book value per share | -2.00 - | -3.98 98.81% | 13.23 432.69% | 2.61 80.31% | 0.00 99.90% | -0.00 168.29% | |
working capital | 36.94M - | 4.23M 88.54% | 171.84M 3,959.56% | 410.87M 139.10% | 8.98M 97.81% | 181.75M 1,924.34% |
All numbers in USD (except ratios and percentages)